Fact CheckerSign in

NCT03635645Recruiting

Experimental and Clinical Studies of Retinal Stimulation

Source: ClinicalTrials.gov · Last updated 14 Dec 2022 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

The study will evaluate new methods of retinal stimulation and training with the goal of improving the visual ability of retinal prosthesis participants.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
20 (estimated)
First submitted
26 Jul 2018
Start date
30 Oct 2017
Primary completion date
30 Oct 2023
Lead sponsor
University of Michigan
NCT number
NCT03635645

What you commit to

  • Study type: Interventional
  • Planned participants: 20
  • From 30 Oct 2017 to the primary completion date, 30 Oct 2023
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Subjects participating in another investigatory drug or device study

Other illness

  • Any disease or condition that prevents understanding or communication of informed consent, study demands, and testing protocols.

Who the study is looking for

  • Must be implanted with an Argus II Retinal Prosthesis system.
  • Have 5 or more electrodes that create a perception with stimulation.
  • Must be willing and able to comply with the protocol testing requirements.

Age in the registry: 25 years to 89 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University of Michigan
Coordinator of this site? Confirm its status
Ann ArborUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.